Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance - Relationship With Selected Immune And Clinical Parameters.

Pasiarski M, Sosnowska-Pasiarska B, Grywalska E, Stelmach-Gołdyś A, Kowalik A, Góźdź S, Roliński J.

Clin Interv Aging. 2019 Oct 9;14:1741-1749. doi: 10.2147/CIA.S220423. eCollection 2019.

2.

Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.

Lasota J, Chłopek M, Lamoureux J, Christiansen J, Kowalik A, Wasąg B, Felisiak-Gołąbek A, Agaimy A, Biernat W, Canzonieri V, Centonze G, Chmielik E, Daum O, Dubová M, Dziuba I, Goertz S, Góźdź S, Guttmejer-Nasierowska A, Haglund C, Hałoń A, Hartmann A, Inaguma S, Iżycka-Świeszewska E, Kaczorowski M, Kita P, Kołos M, Kopczyński J, Michal M, Milione M, Okoń K, Pęksa R, Pyzlak M, Ristimäki A, Ryś J, Szostak B, Szpor J, Szumiło J, Teresiński L, Waloszczyk P, Wejman J, Wesołowski W, Miettinen M.

Am J Surg Pathol. 2019 Sep 23. doi: 10.1097/PAS.0000000000001377. [Epub ahead of print]

PMID:
31567189
3.

Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study.

Kowalik A, Zalewski K, Kopczyński J, Siołek M, Lech M, Hińcza K, Kalisz J, Chrapek M, Zięba S, Furmańczyk J, Jedliński M, Chłopek M, Misiek M, Góźdź S.

Pol J Pathol. 2019;70(2):115-126. doi: 10.5114/pjp.2019.82905.

4.

Programmed cell death 1 expression and Epstein-Barr virus infection in chronic lymphocytic leukaemia: a prospective cohort study.

Grywalska E, Pasiarski M, Sosnowska-Pasiarska B, Macek P, Rolińska A, Samardakiewicz M, Ludian J, Góźdź S, Roliński J.

Cancer Manag Res. 2019 Aug 12;11:7605-7618. doi: 10.2147/CMAR.S212069. eCollection 2019.

5.

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.

Trybek T, Walczyk A, Gąsior-Perczak D, Pałyga I, Mikina E, Kowalik A, Hińcza K, Kopczyński J, Chrapek M, Góźdź S, Kowalska A.

Endocrinology. 2019 Oct 1;160(10):2328-2338. doi: 10.1210/en.2019-00315.

PMID:
31305897
6.

WHO recommendations on physical activity versus compliance rate within a specific urban population as assessed through IPAQ survey: a cross-sectional cohort study.

Macek P, Terek-Derszniak M, Zak M, Biskup M, Ciepiela P, Krol H, Smok-Kalwat J, Gozdz S.

BMJ Open. 2019 Jun 11;9(6):e028334. doi: 10.1136/bmjopen-2018-028334.

7.

New strategy for the gene mutation identification using surface enhanced Raman spectroscopy (SERS).

Kowalczyk A, Krajczewski J, Kowalik A, Weyher JL, Dzięcielewski I, Chłopek M, Góźdź S, Nowicka AM, Kudelski A.

Biosens Bioelectron. 2019 May 1;132:326-332. doi: 10.1016/j.bios.2019.03.019. Epub 2019 Mar 12.

PMID:
30897539
8.

The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.

Kopczyński J, Suligowska A, Niemyska K, Palyga I, Walczyk A, Gąsior-Perczak D, Kowalik A, Hińcza K, Mężyk R, Góźdź S, Kowalska A.

Endokrynol Pol. 2019;70(3):232-236. doi: 10.5603/EP.a2019.0008. Epub 2019 Mar 7.

9.

Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis.

Wątek M, Wnorowska U, Wollny T, Durnaś B, Wolak P, Kościołek-Zgódka S, Pasiarski M, Góźdź S, Bucki R.

Med Sci Monit. 2019 Feb 23;25:1452-1458. doi: 10.12659/MSM.911904.

10.

Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).

Walczyk A, Kopczyński J, Gąsior-Perczak D, Pałyga I, Kowalik A, Chrapek M, Hejnold M, Góźdź S, Kowalska A.

Clin Endocrinol (Oxf). 2019 Aug;91(2):331-339. doi: 10.1111/cen.13910. Epub 2019 Jan 7.

PMID:
30525210
11.

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer.

Grywalska E, Pasiarski M, Góźdź S, Roliński J.

Onco Targets Ther. 2018 Oct 4;11:6505-6524. doi: 10.2147/OTT.S150817. eCollection 2018. Review.

12.

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Gąsior-Perczak D, Pałyga I, Szymonek M, Kowalik A, Walczyk A, Kopczyński J, Lizis-Kolus K, Trybek T, Mikina E, Szyska-Skrobot D, Gadawska-Juszczyk K, Hurej S, Szczodry A, Słuszniak A, Słuszniak J, Mężyk R, Góźdź S, Kowalska A.

PLoS One. 2018 Oct 1;13(10):e0204668. doi: 10.1371/journal.pone.0204668. eCollection 2018.

13.

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.

Kowalik A, Siołek M, Kopczyński J, Krawiec K, Kalisz J, Zięba S, Kozak-Klonowska B, Wypiórkiewicz E, Furmańczyk J, Nowak-Ozimek E, Chłopek M, Macek P, Smok-Kalwat J, Góźdź S.

PLoS One. 2018 Jul 24;13(7):e0201086. doi: 10.1371/journal.pone.0201086. eCollection 2018.

14.

Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.

Zięba S, Kowalik A, Zalewski K, Rusetska N, Goryca K, Piaścik A, Misiek M, Bakuła-Zalewska E, Kopczyński J, Kowalski K, Radziszewski J, Bidziński M, Góźdź S, Kowalewska M.

Gynecol Oncol. 2018 Sep;150(3):552-561. doi: 10.1016/j.ygyno.2018.06.026. Epub 2018 Jul 3.

15.

Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.

Grywalska E, Bartkowiak-Emeryk M, Pasiarski M, Olszewska-Bożek K, Mielnik M, Podgajna M, Pieczykolan M, Hymos A, Fitas E, Surdacka A, Góźdź S, Roliński J.

Adv Clin Exp Med. 2018 Jul;27(7):987-999. doi: 10.17219/acem/74437.

16.

Multielemental Analysis of Tobacco Plant and Tobacco Products by TXRF.

Majewska U, Piotrowska M, Sychowska I, Banas D, Kubala-Kukus A, Wudarczyk-Mocko J, Stabrawa I, Gózdz S.

J Anal Toxicol. 2018 Jul 1;42(6):409-416. doi: 10.1093/jat/bky016.

PMID:
29566234
17.

Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.

Zalewski K, Misiek M, Kowalik A, Bakuła-Zalewska E, Kopczyński J, Zielińska A, Bidziński M, Radziszewski J, Góźdź S, Kowalewska M.

Tumour Biol. 2017 Nov;39(11):1010428317717140. doi: 10.1177/1010428317717140.

PMID:
29299981
18.

Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.

Wątek M, Durnaś B, Wollny T, Pasiarski M, Góźdź S, Marzec M, Chabowska A, Wolak P, Żendzian-Piotrowska M, Bucki R.

Lipids Health Dis. 2017 Dec 8;16(1):235. doi: 10.1186/s12944-017-0624-1.

19.

SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.

Felisiak-Goląbek A, Inaguma S, Kowalik A, Wasąg B, Wang ZF, Zięba S, Pięciak L, Ryś J, Kopczynski J, Sarlomo-Rikala M, Góźdź S, Lasota J, Miettinen M.

Appl Immunohistochem Mol Morphol. 2018 Jan;26(1):40-45. doi: 10.1097/PAI.0000000000000500.

20.

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma.

Szymonek M, Kowalik A, Kopczyński J, Gąsior-Perczak D, Pałyga I, Walczyk A, Gadawska-Juszczyk K, Płusa A, Mężyk R, Chrapek M, Góźdź S, Kowalska A.

Oncotarget. 2017 Aug 24;8(43):74897-74909. doi: 10.18632/oncotarget.20451. eCollection 2017 Sep 26.

21.

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Kowalik A, Gąsior-Perczak D, Gromek M, Siołek M, Walczyk A, Pałyga I, Chłopek M, Kopczyński J, Mężyk R, Kowalska A, Góźdź S.

Oncotarget. 2017 Apr 6;8(35):58304-58308. doi: 10.18632/oncotarget.16870. eCollection 2017 Aug 29.

22.

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine.

Gąsior-Perczak D, Pałyga I, Szymonek M, Kowalik A, Walczyk A, Kopczyński J, Lizis-Kolus K, Słuszniak A, Słuszniak J, Łopatyński T, Mężyk R, Góźdź S, Kowalska A.

Endocr Connect. 2017 Oct;6(7):522-527. doi: 10.1530/EC-17-0135. Epub 2017 Aug 18.

23.

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo.

Durnaś B, Piktel E, Wątek M, Wollny T, Góźdź S, Smok-Kalwat J, Niemirowicz K, Savage PB, Bucki R.

BMC Microbiol. 2017 Jul 26;17(1):167. doi: 10.1186/s12866-017-1075-6.

24.

Morphology with immunohistochemical and genetic profiling of high-grade neuroendocrine carcinoma of colon - a case report with review of literature.

Wincewicz A, Kowalik A, Zięba S, Sułkowski S, Góźdź S.

Rom J Morphol Embryol. 2017;58(2):655-663. Review.

25.

Response to therapy of papillary thyroid cancer of known BRAF status.

Kowalska A, Walczyk A, Kowalik A, Pałyga I, Gąsior-Perczak D, Trybek T, Kopczyński J, Kajor M, Mikina E, Szymonek M, Gadawska-Juszczyk K, Szyska-Skrobot D, Lizis-Kolus K, Hurej S, Chrapek M, Chłopek M, Góźdź S.

Clin Endocrinol (Oxf). 2017 Dec;87(6):815-824. doi: 10.1111/cen.13423. Epub 2017 Aug 4.

PMID:
28718951
26.

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.

Kowalik A, Kowalska A, Walczyk A, Chodurska R, Kopczyński J, Chrapek M, Wypiórkiewicz E, Chłopek M, Pięciak L, Gąsior-Perczak D, Pałyga I, Gruszczyński K, Nowak E, Góźdź S.

PLoS One. 2017 Jun 21;12(6):e0179691. doi: 10.1371/journal.pone.0179691. eCollection 2017.

27.

Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors.

Kowalik A, Kowalewska M, Góźdź S.

Transl Res. 2017 Jul;185:58-84.e15. doi: 10.1016/j.trsl.2017.04.002. Epub 2017 Apr 26. Review.

28.

Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease.

Wollny T, Wątek M, Durnaś B, Niemirowicz K, Piktel E, Żendzian-Piotrowska M, Góźdź S, Bucki R.

Int J Mol Sci. 2017 Mar 31;18(4). pii: E741. doi: 10.3390/ijms18040741. Review.

29.

SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.

Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pięciak L, Zięba S, Pęksa R, Kopczynski J, Okoń K, Waloszczyk P, Gozdz S, Biernat W, Miettinen M.

Arch Pathol Lab Med. 2017 Apr;141(4):564-568. doi: 10.5858/arpa.2016-0147-OA. Epub 2017 Feb 28.

PMID:
28353383
30.

IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.

Fang M, Li Y, Huang K, Qi S, Zhang J, Zgodzinski W, Majewski M, Wallner G, Gozdz S, Macek P, Kowalik A, Pasiarski M, Grywalska E, Vatan L, Nagarsheth N, Li W, Zhao L, Kryczek I, Wang G, Wang Z, Zou W, Wang L.

Cancer Res. 2017 May 15;77(10):2735-2745. doi: 10.1158/0008-5472.CAN-16-1602. Epub 2017 Mar 1.

31.

The role of interleukin 15 in neoplasia.

Chłopek M, Kowalik A, Góźdź S, Koziak K.

Postepy Hig Med Dosw (Online). 2017 Jan 10;71(0):5-19. doi: 10.5604/17322693.1228266. Review.

32.

Leiomyosarcoma FNCLCC G3 pT2B of broad ligament adherent to right oviduct - case report with molecular profiling.

Wincewicz A, Kowalik A, Zięba S, Góźdź S, Woltanowska M.

Rom J Morphol Embryol. 2016;57(4):1409-1414.

33.
34.

Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics.

Niemirowicz K, Durnaś B, Tokajuk G, Głuszek K, Wilczewska AZ, Misztalewska I, Mystkowska J, Michalak G, Sodo A, Wątek M, Kiziewicz B, Góźdź S, Głuszek S, Bucki R.

Nanomedicine. 2016 Nov;12(8):2395-2404. doi: 10.1016/j.nano.2016.07.006. Epub 2016 Jul 25.

PMID:
27464757
35.

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

Kowalska A, Walczyk A, Pałyga I, Gąsior-Perczak D, Gadawska-Juszczyk K, Szymonek M, Trybek T, Lizis-Kolus K, Szyska-Skrobot D, Mikina E, Hurej S, Słuszniak J, Mężyk R, Góźdź S.

PLoS One. 2016 Apr 14;11(4):e0153242. doi: 10.1371/journal.pone.0153242. eCollection 2016.

36.

Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.

Kowalska A, Walczyk A, Kowalik A, Pałyga I, Trybek T, Kopczyński J, Kajor M, Chrapek M, Pięciak L, Chłopek M, Góźdź S, Kamiński G.

Thyroid. 2016 Apr;26(4):543-51. doi: 10.1089/thy.2015.0352. Epub 2016 Feb 18.

PMID:
26889698
37.

The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.

Kowalska A, Kowalik A, Pałyga I, Walczyk A, Gąsior-Perczak D, Kopczyński J, Lizis-Kolus K, Szyska-Skrobot D, Hurej S, Radowicz-Chil A, Chodurska R, Wypiórkiewicz E, Chłopek M, Nowak E, Niemyska K, Góźdź S.

Endokrynol Pol. 2016;67(1):41-7. doi: 10.5603/EP.2016.0006.

38.

Utility of blood procalcitonin concentration in the management of cancer patients with infections.

Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S.

Onco Targets Ther. 2016 Jan 22;9:469-75. doi: 10.2147/OTT.S95600. eCollection 2016. Review.

39.

Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases.

Lasota J, Felisiak-Golabek A, Wasag B, Kowalik A, Zięba S, Chłopek M, Wang ZF, Coates T, Kopczynski J, Gozdz S, Sarlomo-Rikala M, Miettinen M.

Mod Pathol. 2016 Mar;29(3):275-82. doi: 10.1038/modpathol.2015.160. Epub 2016 Jan 22.

40.

Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.

Wincewicz A, Kowalik A, Zięba S, Kopczyński J, Góźdź S, Sulkowski S.

Pol J Pathol. 2016;67(4):307-312. doi: 10.5114/pjp.2016.65860.

41.

Comparative assessment of calcitonin stimulation test using calcium gluconate and pentagastrin and the usefulness of procalcitonin basic and post-stimulation concentrations in the diagnosis of patients after surgery for medullary.

Kowalska A, Lizis-Kolus K, Gąsior-Perczak D, Palyga I, Słuszniak A, Słuszniak J, Antczak G, Lizis P, Mezyk R, Gozdz S.

Neuro Endocrinol Lett. 2016 Dec;37(7):485-490.

PMID:
28326742
42.

Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary.

Kopczynski J, Kowalik A, Chłopek M, Wang ZF, Góźdź S, Lasota J, Miettinen M.

Appl Immunohistochem Mol Morphol. 2016 May-Jun;24(5):e28-33. doi: 10.1097/PAI.0000000000000271.

PMID:
26509912
43.

High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.

Grywalska E, Roliński J, Pasiarski M, Korona-Glowniak I, Maj M, Surdacka A, Grafka A, Stelmach-Gołdyś A, Zgurski M, Góźdź S, Malm A, Grabarczyk P, Starosławska E.

PLoS One. 2015 Oct 13;10(10):e0140178. doi: 10.1371/journal.pone.0140178. eCollection 2015.

44.

The Role of Cathelicidin LL-37 in Cancer Development.

Piktel E, Niemirowicz K, Wnorowska U, Wątek M, Wollny T, Głuszek K, Góźdź S, Levental I, Bucki R.

Arch Immunol Ther Exp (Warsz). 2016 Feb;64(1):33-46. doi: 10.1007/s00005-015-0359-5. Epub 2015 Sep 22. Review.

45.

The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.

Kowalska A, Pałyga I, Gąsior-Perczak D, Walczyk A, Trybek T, Słuszniak A, Mężyk R, Góźdź S.

PLoS One. 2015 Jul 31;10(7):e0133852. doi: 10.1371/journal.pone.0133852. eCollection 2015.

46.

α-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation: A Case Study With Molecular Profiling.

Wincewicz A, Kowalik A, Zięba S, Lewitowicz P, Góźdź S, Sulkowski S.

Int J Surg Pathol. 2015 Oct;23(7):537-41. doi: 10.1177/1066896915586807. Epub 2015 May 25.

PMID:
26009570
47.

CHEK2 mutations and the risk of papillary thyroid cancer.

Siołek M, Cybulski C, Gąsior-Perczak D, Kowalik A, Kozak-Klonowska B, Kowalska A, Chłopek M, Kluźniak W, Wokołorczyk D, Pałyga I, Walczyk A, Lizis-Kolus K, Sun P, Lubiński J, Narod SA, Góźdż S.

Int J Cancer. 2015 Aug 1;137(3):548-52. doi: 10.1002/ijc.29426. Epub 2015 Jan 28.

48.

Assessment of peripheral blood and bone marrow T, NK, NKT and dendritic cells in patients with multiple myeloma.

Pasiarski M, Grywalska E, Kosmaczewska A, Góźdź S, Steckiewicz P, Garus B, Bilski M, Hymos A, Roliński J, Bilski M, Roliński J.

Postepy Hig Med Dosw (Online). 2015 Dec 31;69:1435-42. Review.

49.

Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Pasiarski M, Rolinski J, Grywalska E, Stelmach-Goldys A, Korona-Glowniak I, Gozdz S, Hus I, Malm A.

PLoS One. 2014 Dec 15;9(12):e114966. doi: 10.1371/journal.pone.0114966. eCollection 2014.

50.

Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.

Lasota J, Kowalik A, Wasag B, Wang ZF, Felisiak-Golabek A, Coates T, Kopczynski J, Gozdz S, Miettinen M.

Am J Surg Pathol. 2014 Sep;38(9):1235-41. doi: 10.1097/PAS.0000000000000229.

Supplemental Content

Support Center